Unclear : This was one of many trials that have been conducted with Benicar (olmesartan) which showed a slight increase in mortality among "high risk" diabetic patients (as compared to placebo patients). That said, there was a lot of criticism of these findings - and when additional studies were conducted - the same results were not replicated. Here's a great article: http://www.medscape.com/viewarticle/827288
Answered 2/21/2015
3.2k views
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question